PegBio
Hangzhou, CN · 1 known investors
PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders. Using its proprietary HECTOR technology platform, it designs peptide, protein, and small-molecule drug candidates targeting conditions such as type 2 diabetes, obesity, MASH, opioid-induced constipation, and congenital hyperinsulinism.
Investors · 1
Frequently asked questions
- What does PegBio do?
- PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders. Using its proprietary HECTOR technology platform, it designs peptide, protein, and small-molecule drug candidates targeting conditions such as type 2 diabetes, obesity, MASH, opioid-induced constipation, and congenital hyperinsulinism.
- Who are PegBio's investors?
- PegBio's investors include YuanBio Venture Capital.
- Where is PegBio headquartered?
- PegBio is headquartered in Hangzhou, CN.